FDA
-
-
-
-
-
-
-
ADC Therapeutics Announces New Employee Inducement Grant
-
-
-
-
-
-
-
ADC Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Updates
-
-
-
-
-
-
-
ADC Therapeutics to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on March 10, 2026
-
-
-
-
-
-
-
ADC Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
-
-
-
-
-
-
-
ADC Therapeutics to Host Third Quarter 2025 Financial Results Conference Call on November 10, 2025
-
-
-
-
-
-
-
ADC Therapeutics to Present at the Cantor Global Healthcare Conference 2025
-
-
-
-
-
-
-
ADC Therapeutics Announces Updated ZYNLONTA® Investigator-Initiated Trial Data in R/R Marginal Zone Lymphoma Presented at 18th International Conference on Malignant Lymphoma (ICML)
-
335,369 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


